{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:14:11Z","timestamp":1761059651912},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1824-7288-40-2","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T12:02:12Z","timestamp":1389182532000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Refractory invasive aspergillosis controlled with posaconazole and pulmonary surgery in a patient with chronic granulomatous disease: case report"],"prefix":"10.1186","volume":"40","author":[{"given":"Eda","family":"Kepenekli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Soysal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canan","family":"Kuzdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nezih Onur","family":"Ermerak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Y\u00fcksel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Bak\u0131r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,8]]},"reference":[{"key":"550_CR1","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S0952-7915(03)00109-2","volume":"15","author":"PG Heyworth","year":"2003","unstructured":"Heyworth PG, Cross AR, Curnutte JT: Chronic granulomatous disease. Curr Opin Immunol. 2003, 15: 578-584. 10.1016\/S0952-7915(03)00109-2.","journal-title":"Curr Opin Immunol"},{"key":"550_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1365-2141.2007.06880.x","volume":"140","author":"RA Seger","year":"2003","unstructured":"Seger RA: Modern management of chronic granulomatous disease. Br J Haematol. 2003, 140: 255-266.","journal-title":"Br J Haematol"},{"key":"550_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/00005792-200005000-00004","volume":"79","author":"BH Segal","year":"2000","unstructured":"Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM: Genetic, biochemical and clinical features of chronic granulomatous disease. Medicine. 2000, 79: 170-200. 10.1097\/00005792-200005000-00004.","journal-title":"Medicine"},{"key":"550_CR4","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1182\/blood-2002-02-0583","volume":"100","author":"RA Seger","year":"2002","unstructured":"Seger RA, Gungor T, Belohradsky BH: Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985\u20132000. Blood. 2002, 100: 4344-4350. 10.1182\/blood-2002-02-0583.","journal-title":"Blood"},{"key":"550_CR5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1056\/NEJM200103223441203","volume":"344","author":"ME Horwitz","year":"2001","unstructured":"Horwitz ME, Barret AJ, Brown MR: Treatment of chronic granulomatous disease with myeloablative conditioning and t-cell depleted hematopoietic allograft. N Engl J Med. 2001, 344: 881-888. 10.1056\/NEJM200103223441203.","journal-title":"N Engl J Med"},{"key":"550_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.clim.2007.09.008","volume":"126","author":"B Martire","year":"2008","unstructured":"Martire B, Rondelli R, Soresina A: Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study. Clin Immunol. 2008, 126: 155-164. 10.1016\/j.clim.2007.09.008.","journal-title":"Clin Immunol"},{"issue":"12","key":"550_CR7","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1093\/cid\/cir731","volume":"53","author":"S Blumental","year":"2011","unstructured":"Blumental S, Mouy R, Mahlaoui N, Bougnoux ME, Debr\u00e9 M, Beaut\u00e9 J, Lortholary O, Blanche S, Fischer A: Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey. Clin Infect Dis. 2011, 53 (12): e159-e169. 10.1093\/cid\/cir731.","journal-title":"Clin Infect Dis"},{"key":"550_CR8","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0022-3476(05)82023-2","volume":"125","author":"R Mouy","year":"1994","unstructured":"Mouy R, Veber F, Blanche S: Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease. J Pediatr. 1994, 125: 998-1003. 10.1016\/S0022-3476(05)82023-2.","journal-title":"J Pediatr"},{"key":"550_CR9","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa021931","volume":"348","author":"JI Gallin","year":"2003","unstructured":"Gallin JI, Alling DW, Malech HL: Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med. 2003, 348: 2416-2422. 10.1056\/NEJMoa021931.","journal-title":"N Engl J Med"},{"key":"550_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/00005792-200007000-00006","volume":"79","author":"TF Patterson","year":"2000","unstructured":"Patterson TF, Kirkpatrick WR, White M: Invasive aspergillosis: disease spectrum, treatment practices, and outcomes. Medicine. 2000, 79: 250-260. 10.1097\/00005792-200007000-00006.","journal-title":"Medicine"},{"key":"550_CR11","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0891-5520(02)00035-1","volume":"16","author":"KA Marr","year":"2002","unstructured":"Marr KA, Patterson T, Denning D: Aspergillosis: pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am. 2002, 16: 875-894. 10.1016\/S0891-5520(02)00035-1.","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"550_CR12","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/QCO.0b013e328358b0a4","volume":"25","author":"EL Falcone","year":"2012","unstructured":"Falcone EL, Holland SM: Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management. Curr Opin Infect Dis. 2012, 25 (6): 658-669. 10.1097\/QCO.0b013e328358b0a4.","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"550_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/INF.0b013e3181f13b23","volume":"30","author":"J Beaute","year":"2011","unstructured":"Beaute J, Obenga G, Le Mignot L, Mahlaoui N, Bougnoux ME, Mouy R: Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease. Pediatr Infect Dis J. 2011, 30 (1): 57-62. 10.1097\/INF.0b013e3181f13b23.","journal-title":"Pediatr Infect Dis J"},{"key":"550_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/525258","volume":"46","author":"TJ Walsh","year":"2008","unstructured":"Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA: Treatment of aspergillosis: clinical practice guidelines of the infectious diseases society of America. Clin Infect Dis. 2008, 46: 327-360. 10.1086\/525258.","journal-title":"Clin Infect Dis"},{"key":"550_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1086\/508774","volume":"44","author":"TJ Walsh","year":"2007","unstructured":"Walsh TJ, Raad I, Patterson TF, Chandrasekar P, Donowitz GR, Graybill R: Treatment of invasive aspergillozis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clin Infect Dis. 2007, 44: 2-22. 10.1086\/508774.","journal-title":"Clin Infect Dis"},{"key":"550_CR16","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1086\/430068","volume":"40","author":"BH Segal","year":"2005","unstructured":"Segal BH, Barnhart LA, Anderson VL, Walsh TJ, Malech HL, Holland SM: Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection. Clin Infect Dis. 2005, 40: 1684-1688. 10.1086\/430068.","journal-title":"Clin Infect Dis"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1824-7288-40-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T13:03:49Z","timestamp":1630587829000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/1824-7288-40-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,8]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["550"],"URL":"https:\/\/doi.org\/10.1186\/1824-7288-40-2","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,8]]},"assertion":[{"value":"7 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"2"}}